ES2052173T3 - Composiciones inyectables que contienen 25-cyclohexil-avermectina b1. - Google Patents

Composiciones inyectables que contienen 25-cyclohexil-avermectina b1.

Info

Publication number
ES2052173T3
ES2052173T3 ES90303716T ES90303716T ES2052173T3 ES 2052173 T3 ES2052173 T3 ES 2052173T3 ES 90303716 T ES90303716 T ES 90303716T ES 90303716 T ES90303716 T ES 90303716T ES 2052173 T3 ES2052173 T3 ES 2052173T3
Authority
ES
Spain
Prior art keywords
avermectin
cyclohexil
compositions containing
injectable compositions
parabitants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90303716T
Other languages
English (en)
Spanish (es)
Inventor
Stephen Richard Wicks
Edward Davison
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PFIZER
Pfizer Inc
Original Assignee
PFIZER
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898908071A external-priority patent/GB8908071D0/en
Application filed by PFIZER, Pfizer Inc filed Critical PFIZER
Application granted granted Critical
Publication of ES2052173T3 publication Critical patent/ES2052173T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
ES90303716T 1989-04-11 1990-04-06 Composiciones inyectables que contienen 25-cyclohexil-avermectina b1. Expired - Lifetime ES2052173T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898908071A GB8908071D0 (en) 1989-04-11 1989-04-11 Antiparasitic formulations
SG27894A SG27894G (en) 1989-04-11 1994-02-22 Injectable compositions containing 25-cyclohexyl-avermectin B1

Publications (1)

Publication Number Publication Date
ES2052173T3 true ES2052173T3 (es) 1994-07-01

Family

ID=26295191

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90303716T Expired - Lifetime ES2052173T3 (es) 1989-04-11 1990-04-06 Composiciones inyectables que contienen 25-cyclohexil-avermectina b1.

Country Status (16)

Country Link
EP (1) EP0393890B1 (enExample)
JP (1) JPH0647548B2 (enExample)
CN (1) CN1035356C (enExample)
AP (1) AP133A (enExample)
AU (1) AU609660B2 (enExample)
CY (1) CY1777A (enExample)
DK (1) DK0393890T3 (enExample)
EG (1) EG18956A (enExample)
ES (1) ES2052173T3 (enExample)
FI (1) FI92015C (enExample)
GR (1) GR3005794T3 (enExample)
HK (1) HK39294A (enExample)
NO (1) NO175882C (enExample)
OA (1) OA09203A (enExample)
RU (1) RU1836084C (enExample)
SG (1) SG27894G (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
WO1997046204A2 (en) * 1996-06-05 1997-12-11 Ashmont Holdings Limited Injectable compositions
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
KR20000025762A (ko) * 1998-10-14 2000-05-06 유충식 이버멕틴류의 가용화 조성물
GB9827727D0 (en) 1998-12-16 1999-02-10 Pfizer Ltd Antiparasitic formulations
NZ590141A (en) * 2008-06-24 2012-05-25 Merial Ltd Anthelminthic formulations including castor oil and another vegetable oil
ES2399228T3 (es) * 2009-02-16 2013-03-26 Ah Usa 42 Llc Formulación de doramectina a dosis elevada
MX2012004133A (es) * 2009-10-07 2012-05-08 Wyeth Llc Composiciones que comprenden adyuvante, macrolido y antigeno proteico y procedimientos de uso de las mismas.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3532794A1 (de) * 1984-09-14 1986-04-17 Glaxo Group Ltd., London Antibiotika, verfahren zu deren herstellung und diese verbindungen enthaltende mittel
ES8802229A1 (es) * 1985-04-30 1988-04-16 Glaxo Group Ltd Un procedimiento para preparar nuevos derivados lactonicos macrociclicos.
US4707470A (en) * 1985-05-17 1987-11-17 Smithkline Beckman Corporation Polyene antibiotic emulsion formulation
EP0285561A3 (de) * 1987-03-27 1989-10-25 Ciba-Geigy Ag Parasitizide und insektizide Milbemycin-Derivate
CA1340771C (en) * 1987-11-09 1999-09-28 Shih-Jen Edward Lee Ethylated avermectins

Also Published As

Publication number Publication date
FI901816A0 (fi) 1990-04-10
NO901637D0 (no) 1990-04-10
CN1046282A (zh) 1990-10-24
NO175882B (no) 1994-09-19
FI92015B (fi) 1994-06-15
NO901637L (no) 1990-10-12
JPH0647548B2 (ja) 1994-06-22
EP0393890B1 (en) 1992-08-12
NO175882C (no) 1994-12-28
RU1836084C (ru) 1993-08-23
AP9000174A0 (en) 1990-04-30
DK0393890T3 (da) 1992-09-28
AU609660B2 (en) 1991-05-02
SG27894G (en) 1995-03-17
AU5311990A (en) 1990-11-08
OA09203A (fr) 1992-06-30
CN1035356C (zh) 1997-07-09
EP0393890A1 (en) 1990-10-24
HK39294A (en) 1994-05-06
JPH02290820A (ja) 1990-11-30
CY1777A (en) 1995-10-20
EG18956A (en) 1994-04-30
GR3005794T3 (enExample) 1993-06-07
FI92015C (fi) 1994-09-26
AP133A (en) 1991-06-05

Similar Documents

Publication Publication Date Title
MX9306499A (es) Composiciones farmaceuticas que contienen una anfetamina.
ES2175125T3 (es) Emulsionantes aceite/agua.
BG102425A (en) (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors
ES2136910T3 (es) Solucion de interferon.
ES2104710T3 (es) Alteracion del ritmo y el tipo de crecimiento de pelo.
FI954963A0 (fi) Poly-1-n-alkeeniamiineja ja näitä sisältäviä poltto- ja voiteluainekoostumuksia
ES2124479T3 (es) Composiciones biocidas.
DE68917776D1 (de) Enzymatische Waschmittel- und Bleichzusammensetzung.
ES2060647T3 (es) Composicion blanqueante.
ES2114487B1 (es) Mezcla estabilizante sinergistica.
ES2140473T3 (es) Derivado fosfolipido y liposoma que lo contiene.
MX9102016A (es) Composicion detergente
DE69815549D1 (de) Pestizide zusammensetzung
FI893805L (fi) Fettsyrakomposition.
TR25422A (tr) Poliol poliesterler ve azalmtilmis kalorili trigliseritler iceren azaltilmis kalorili yag bilesimleri.
DE3872398D1 (de) Enzymatische waschmittelzusammensetzung.
ES2116279T3 (es) Composicion de caucho.
MX9804588A (es) Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
DE69006854D1 (de) Anhaftende selbstverkapselnde spritzzusammensetzungen von bioregulatorischen agenzien.
MX9102545A (es) Composicion de elastomero reforzado y proceso parasu preparacion.
ES2170143T3 (es) Composiciones que comprenden halofantrina en una forma especial.
ES2092868T3 (es) Utilizacion de derivados de la 4-tiorresorcina en unas composiciones cosmeticas o dermofarmaceuticas de accion despigmentante.
BR9504771A (pt) Composição anidra de uso tópico e processo de preparação de uma composição
CO4600725A1 (es) Composiciones insecticidas sinergisticas
ES2160379T3 (es) Composicion detergente.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 393890

Country of ref document: ES